- Home
- STRO vs WHF Comparison
STRO vs WHF Comparison
Compare STRO & WHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | STRO | WHF |
|---|---|---|
| Founded | 2003 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.0M | 162.2M |
| IPO Year | 2018 | 2012 |
Fundamental Metrics
Financial Performance| Metric | STRO | WHF |
|---|---|---|
| Price | $11.49 | $6.98 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 8 | 2 |
| Target Price | ★ $18.29 | $7.75 |
| AVG Volume (30 Days) | 125.6K | ★ 240.0K |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | N/A | ★ 25.57% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.42 |
| Revenue | ★ $105,646,000.00 | $76,339,000.00 |
| Revenue This Year | $63.08 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $16.46 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.23 | $6.39 |
| 52 Week High | $21.50 | $11.31 |
Technical Indicators
Market Signals| Indicator | STRO | WHF |
|---|---|---|
| Relative Strength Index (RSI) | 82.73 | 40.66 |
| Support Level | $8.49 | $6.76 |
| Resistance Level | $11.09 | $7.08 |
| Average True Range (ATR) | 0.87 | 0.20 |
| MACD | 0.03 | -0.07 |
| Stochastic Oscillator | 83.01 | 17.59 |
Price Performance
Historical ComparisonAbout STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About WHF WhiteHorse Finance Inc.
WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate risk-adjusted returns by originating and investing in senior secured loans, including first lien and second lien facilities, to performing lower middle market companies across a range of industries.